Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy

(2015) Bo Cao et al.   Oncotarget

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

(2014) Z. Yu et al.   CLINICAL CANCER RESEARCH

The utility of prostate-specific antigen in the management of advanced prostate cancer

(2013) E. David Crawford et al.   BJU INTERNATIONAL

Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors

(2013) Feng Sun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy

(2012) Yuan-Yuan Qu et al.   ASIAN JOURNAL OF ANDROLOGY

Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death

(2012) Pier Vitale Nuzzo et al.   BMC CANCER

A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!

(2012) Zhiyong Guo et al.   International Journal of Biological Sciences

Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal

(2012) Siu Chiu Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcript Levels of Androgen Receptor Variant AR-V1 or AR-V7 Do Not Predict Recurrence in Patients with Prostate Cancer at Indeterminate Risk for Progression

(2012) Hongjuan Zhao et al.   JOURNAL OF UROLOGY

Alternatively spliced androgen receptor variants

(2011) Scott M Dehm et al.   ENDOCRINE-RELATED CANCER

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

(2011) Kristin R. Lamont et al.   MOLECULAR ENDOCRINOLOGY

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

(2011) Emma Hörnberg et al.   PLoS One

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases

(2011) Xiaotun Zhang et al.   PLoS One

A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities

(2011) Rong Hu et al.   PROSTATE

Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study

(2010) Carmen Mir et al.   BJU INTERNATIONAL

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

(2010) Shihua Sun et al.   JOURNAL OF CLINICAL INVESTIGATION

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

(2010) P. A. Watson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells

(2010) Xunxian Liu et al.   PROSTATE

Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients

(2009) Guo-Wen Lin et al.   ASIAN JOURNAL OF ANDROLOGY

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

(2009) Z. Guo et al.   CANCER RESEARCH

Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels

(2008) Bo Dai et al.   ASIAN JOURNAL OF ANDROLOGY

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

(2008) S. M. Dehm et al.   CANCER RESEARCH

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

(2008) R. Hu et al.   CANCER RESEARCH

PSA HALF LIFE AND PSA DOUBLING TIME AS A PREDICTOR OF RESPONSE TO ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER

(2008) Yong Hyun Park et al.   JOURNAL OF UROLOGY